ESC 365 - Real-world results of selexipag in treating pulmonary hypertension in a portuguese population

HFA Premium Access

Real-world results of selexipag in treating pulmonary hypertension in a portuguese population

Session: ePosters in valvular and pulmonary 4

Topic: Pulmonary Hypertension

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Joana Mesquita Guimaraes

University Hospitals of Coimbra, Coimbra (Portugal)

1 presentation

0 follower

3 more presentations in this session

Exploring the clinical relevance of TSAT <21% as an iron deficiency indicator in pulmonary arterial hypertension: a comparative analysis with alternative criteria and existing guidelines

Speaker: Doctor N. Ilchyshyn (Almada, PT)

Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

HFWM: exploring biomarkers in chronic thromboembolic pulmonary hypertension (CTEPH): prognostic significance, and post-PEA dynamics analysis

Speaker: Doctor A. Cuomo (Napoly, IT)

Access the full session

ePosters in valvular and pulmonary 4

Speakers: Doctor J. Mesquita Guimaraes, Doctor N. Ilchyshyn, Doctor J. Mesquita Guimaraes, Doctor A. Cuomo

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources